思泉新材(301489.SZ):擬增加越南思泉新材散熱產品項目投資總額
格隆匯2月27日丨思泉新材(301489.SZ)公佈,公司於2025年2月26日召開的第三屆董事會第二十次會議審議通過了《關於增加越南思泉新材散熱產品項目投資總額的議案》,鑑於越南思泉新材散熱產品項目的規劃用地及主要經營產品範圍增加,將導致上述投資項目建築工程相關費用、設備購置費、設備安裝費及運營資金等較前期投資計劃增加。因此,同意公司將越南思泉新材散熱產品項目的投資總額從3500萬美元增加至6500萬美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.